COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges
Lung cancer, considered one of the most common causes of cancer deaths worldwide, is a complex disease with its own challenges. The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), compounded these challenges and forced the medical...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2022-09-01
|
| Series: | Journal of International Medical Research |
| Online Access: | https://doi.org/10.1177/03000605221125047 |
| _version_ | 1828373598039965696 |
|---|---|
| author | Simon Moubarak Diala Merheb Lynn Basbous Nathalie Chamseddine Maroun Bou Zerdan Hazem I Assi |
| author_facet | Simon Moubarak Diala Merheb Lynn Basbous Nathalie Chamseddine Maroun Bou Zerdan Hazem I Assi |
| author_sort | Simon Moubarak |
| collection | DOAJ |
| description | Lung cancer, considered one of the most common causes of cancer deaths worldwide, is a complex disease with its own challenges. The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), compounded these challenges and forced the medical healthcare system to alter its approach to lung cancer. This narrative review aims to identify the effect of the COVID-19 pandemic on lung cancer screening, diagnosis and management. During this public health crisis, various medical societies have worked on developing guidelines to protect patients with lung cancer from the deleterious effects of SARS-CoV-2 infection, as well as from the complications imposed by treatment delays. The different therapeutic approaches, such as surgery, radiation oncology and immune checkpoint inhibitor therapy, along with the latest international recommendations, will be discussed. Protecting patients with lung cancer from COVID-19 complications, while avoiding barriers in treatment delays, has brought unique challenges to healthcare facilities. Prompt modifications to guidelines, and constant evaluation of their efficacy, are thus needed. |
| first_indexed | 2024-04-14T07:21:10Z |
| format | Article |
| id | doaj.art-d308afd781584681b61f2b63af897db9 |
| institution | Directory Open Access Journal |
| issn | 1473-2300 |
| language | English |
| last_indexed | 2024-04-14T07:21:10Z |
| publishDate | 2022-09-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Journal of International Medical Research |
| spelling | doaj.art-d308afd781584681b61f2b63af897db92022-12-22T02:06:10ZengSAGE PublishingJournal of International Medical Research1473-23002022-09-015010.1177/03000605221125047COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challengesSimon MoubarakDiala MerhebLynn BasbousNathalie ChamseddineMaroun Bou ZerdanHazem I AssiLung cancer, considered one of the most common causes of cancer deaths worldwide, is a complex disease with its own challenges. The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), compounded these challenges and forced the medical healthcare system to alter its approach to lung cancer. This narrative review aims to identify the effect of the COVID-19 pandemic on lung cancer screening, diagnosis and management. During this public health crisis, various medical societies have worked on developing guidelines to protect patients with lung cancer from the deleterious effects of SARS-CoV-2 infection, as well as from the complications imposed by treatment delays. The different therapeutic approaches, such as surgery, radiation oncology and immune checkpoint inhibitor therapy, along with the latest international recommendations, will be discussed. Protecting patients with lung cancer from COVID-19 complications, while avoiding barriers in treatment delays, has brought unique challenges to healthcare facilities. Prompt modifications to guidelines, and constant evaluation of their efficacy, are thus needed.https://doi.org/10.1177/03000605221125047 |
| spellingShingle | Simon Moubarak Diala Merheb Lynn Basbous Nathalie Chamseddine Maroun Bou Zerdan Hazem I Assi COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges Journal of International Medical Research |
| title | COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges |
| title_full | COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges |
| title_fullStr | COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges |
| title_full_unstemmed | COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges |
| title_short | COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges |
| title_sort | covid 19 and lung cancer update on the latest screening diagnosis management and challenges |
| url | https://doi.org/10.1177/03000605221125047 |
| work_keys_str_mv | AT simonmoubarak covid19andlungcancerupdateonthelatestscreeningdiagnosismanagementandchallenges AT dialamerheb covid19andlungcancerupdateonthelatestscreeningdiagnosismanagementandchallenges AT lynnbasbous covid19andlungcancerupdateonthelatestscreeningdiagnosismanagementandchallenges AT nathaliechamseddine covid19andlungcancerupdateonthelatestscreeningdiagnosismanagementandchallenges AT marounbouzerdan covid19andlungcancerupdateonthelatestscreeningdiagnosismanagementandchallenges AT hazemiassi covid19andlungcancerupdateonthelatestscreeningdiagnosismanagementandchallenges |